Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: alan laValley who wrote (21730)	5/8/1999 10:30:00 AM
From: VLAD	Read Replies (4) \| Respond to of 23519

alan, True but this is not a patient market we are in. It is a market filled with day traders and those who want instant results. But even from a long term perspective the stock is a sick joke at 5 bucks since it IPO'd in 1994 at 7 bucks and traded in its first year at 7 to 8 bucks. Look at this chart: finance.yahoo.com IMO its as if the company gets negative credit for its accomplishments over the past 5 years while in fact things now look better than ever. In 1996 Vivus didn't even have an approved product and we were trading above 20. Now we have a safe and effective product rolling out into a global market and at least several potential block buster products in the R&D pipe line and yet we trade at 5 bucks. Compare us to ZONA, ICOS, MCHM for ED plays or CEPH or LIPO for small cap biotech plays and tell me where the logic is for a "reasonable" valuation of 5 bucks? IMO if it wasn't for market manipulation and the lies disseminated by the short interest we would have had no business ever trading under 6 or 7 bucks a share.